SARENA KELLY: Open Payments
NPI 1124392352 · BRIDGEPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 56 payments from 17 companies in 2025. Trend: 2023 $1,952 · 2024 $1,395 · 2025 $1,476
Food & beverage: $1,381Education: $95
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $223 |
| ABBVIE INC. | 9 | $186 |
| Janssen Biotech, Inc. | 5 | $160 |
| AstraZeneca Pharmaceuticals LP | 5 | $132 |
| Aurinia Pharma U.S., Inc. | 4 | $106 |
| Mallinckrodt Hospital Products Inc. | 3 | $103 |
| E.R. Squibb & Sons, L.L.C. | 4 | $88 |
| UCB, Inc. | 2 | $78 |
| Lilly USA, LLC | 3 | $71 |
| GlaxoSmithKline, LLC. | 3 | $70 |
Products named: RINVOQ, TREMFYA, LUPKYNIS, ACTHAR, SAPHNELO, ORENCIA, ENBREL, TAVNEOS.
Industry payments across CT — which companies pay providers there.
